According to the research report, the global point-of-care biosensors market size is expected to touch USD 159.01 Billion by 2032, from USD 71.24 Billion in 2022, growing with a significant CAGR of 8.36% from 2023 to 2032.
The point-of-care biosensors report offers a comprehensive study of the current state expected at the major drivers, market strategies, and key vendors’ growth. The report presents energetic visions to conclude and study the market size, market hopes, and competitive surroundings. The research also focuses on the important achievements of the market, research & development, and regional growth of the leading competitors operating in the market. The current trends of the global point-of-care biosensors in conjunction with the geographical landscape of this vertical have also been included in this report.
The report offers intricate dynamics about different aspects of the global point-of-care biosensors market, which aids companies operating in the market in making strategic development decisions. The study also elaborates on significant changes that are highly anticipated to configure growth of the global point-of-care biosensors during the forecast period. It also includes a key indicator assessment that highlights growth prospects of this market and estimates statistics related to growth of the market in terms of value (US$ Mn) and volume (tons).
Sample Link @ https://www.precedenceresearch.com/sample/2885
Report Scope of the Point-of-care Biosensors Market:
| Report Coverage | Details |
| Market Size in 2023 | USD 77.2 Billion |
| Market Size by 2032 | USD 159.01 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.36% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product, By Platforms, By Purchase, By Sample, and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
This study covers a detailed segmentation of the global point-of-care biosensors market, along with key information and a competition outlook. The report mentions company profiles of players that are currently dominating the global point-of-care biosensors market, wherein various developments, expansions, and winning strategies practiced and implemented by leading players have been presented in detail.
Key Players
- Abaxis
- Abbott Laboratories
- Accubiotech Co, Ltd.
- ACON Laboratories, Inc
- Becton, Dickinson and Company
- Biolytical Laboratories
- Danaher Corporation (HemoCue)
- Siemens Healthineers
- Meridian Bioscience, Inc
Market Segmentation
By Product
- Glucose Monitoring
- HIV
- Hepatitis C
- Pregnancy
By Platforms
- Microfluidics
- Dipsticks
- Immunoassays
By Purchase
- OTC
- Prescription
By Sample
- Blood
- Urine
By End User
- Pharmacy
- Hospital
- Homecare
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Research Methodology
The research methodology adopted by analysts for compiling the global point-of-care biosensors report is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information that is obtained and legitimated by market-admissible resources, analysts have offered riveting observations and authentic forecasts for the global market.
During the primary research phase, analysts interviewed market stakeholders, investors, brand managers, vice presidents, and sales and marketing managers. Based on data obtained through interviews of genuine resources, analysts have emphasized the changing scenario of the global market.
For secondary research, analysts scrutinized numerous annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the global point-of-care biosensors market.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Point-of-care Biosensors Market
5.1. COVID-19 Landscape: Point-of-care Biosensors Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Point-of-care Biosensors Market, By Product
8.1. Point-of-care Biosensors Market Revenue and Volume, by Product, 2023-2032
8.1.1. Glucose Monitoring
8.1.1.1. Market Revenue and Volume Forecast (2020-2032)
8.1.2. HIV
8.1.2.1. Market Revenue and Volume Forecast (2020-2032)
8.1.3. Hepatitis C
8.1.3.1. Market Revenue and Volume Forecast (2020-2032)
8.1.4. Pregnancy
8.1.4.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 9. Global Point-of-care Biosensors Market, By Platforms
9.1. Point-of-care Biosensors Market Revenue and Volume, by Platforms, 2023-2032
9.1.1. Microfluidics
9.1.1.1. Market Revenue and Volume Forecast (2020-2032)
9.1.2. Dipsticks
9.1.2.1. Market Revenue and Volume Forecast (2020-2032)
9.1.3. Immunoassays
9.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 10. Global Point-of-care Biosensors Market, By Purchase
10.1. Point-of-care Biosensors Market Revenue and Volume, by Purchase, 2023-2032
10.1.1. OTC
10.1.1.1. Market Revenue and Volume Forecast (2020-2032)
10.1.2. Prescription
10.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 11. Global Point-of-care Biosensors Market, By Sample
11.1. Point-of-care Biosensors Market Revenue and Volume, by Sample, 2023-2032
11.1.1. Blood
11.1.1.1. Market Revenue and Volume Forecast (2020-2032)
11.1.2. Urine
11.1.2.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 12. Global Point-of-care Biosensors Market, By End User
12.1. Point-of-care Biosensors Market Revenue and Volume, by End User, 2023-2032
12.1.1. Pharmacy
12.1.1.1. Market Revenue and Volume Forecast (2020-2032)
12.1.2. Hospital
12.1.2.1. Market Revenue and Volume Forecast (2020-2032)
12.1.3. Homecare
12.1.3.1. Market Revenue and Volume Forecast (2020-2032)
Chapter 13. Global Point-of-care Biosensors Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.6. U.S.
13.1.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.6.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.1.7.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.1.7.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.1.7.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.1.7.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2. Europe
13.2.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.6. UK
13.2.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.7. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.8. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.9. Germany
13.2.9.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.9.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.9.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.10. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.11. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.12. France
13.2.12.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.12.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.12.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.12.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.13. Market Revenue and Volume Forecast, by End User (2020-2032)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.2.14.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.2.14.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.2.14.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.2.15. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3. APAC
13.3.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.6. India
13.3.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.8. China
13.3.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.10. Japan
13.3.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.3.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.3.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.3.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.3.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4. MEA
13.4.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.6. GCC
13.4.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.8. North Africa
13.4.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.9. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.10. South Africa
13.4.10.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.10.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.10.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.10.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.10.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.4.11.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.4.11.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.4.11.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.4.11.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5. Latin America
13.5.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.5. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.6. Brazil
13.5.6.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.6.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.6.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.6.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.7. Market Revenue and Volume Forecast, by End User (2020-2032)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Volume Forecast, by Product (2020-2032)
13.5.8.2. Market Revenue and Volume Forecast, by Platforms (2020-2032)
13.5.8.3. Market Revenue and Volume Forecast, by Purchase (2020-2032)
13.5.8.4. Market Revenue and Volume Forecast, by Sample (2020-2032)
13.5.8.5. Market Revenue and Volume Forecast, by End User (2020-2032)
Chapter 14. Company Profiles
14.1. Abaxis
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Abbott Laboratories
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Accubiotech Co, Ltd.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. ACON Laboratories, Inc
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Becton, Dickinson and Company
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Biolytical Laboratories
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Danaher Corporation (HemoCue)
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Siemens Healthineers
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Meridian Bioscience, Inc
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
PROCEED TO BUY
| Single User License | USD 5400 |
| Multi User License | USD 7900 |
| Corporate License | USD 9900 |
Proceed to checkout
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client
About
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
Blog: https://www.pharma-geek.com
0 Comments